Shardul Amarchand Mangaldas & Co. Advises Krishna Institute of Medical Sciences on Rs.1,500 Crore QIP

Krishna Institute of Medical Sciences (KIMS) has raised approximately Rs.1,500 crore through a Qualified Institutions Placement (QIP), strengthening its growth and expansion plans. Shardul Amarchand Mangaldas & Co. acted as legal counsel, advising on the successful capital markets transaction.

Shardul Amarchand Mangaldas Advises NextGen Invent Corporation on Acquisition by Straive

Shardul Amarchand Mangaldas & Co. advised NextGen Invent Corporation and NGI Ventures on their acquisition by Straive, an EQT portfolio company. The deal strengthens Straive’s Data and AI capabilities while expanding its enterprise AI solutions and global technology services offerings.